Boston, MA -- (SBWIRE) -- 12/06/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Exide Technologies(OTCMKTS:XIDEQ), Authentidate Holding Corp.(NASDAQ:ADAT), Orexigen Therapeutics, Inc.(NASDAQ:OREX), Newmont Mining Corp(NYSE:NEM)
Exide Technologies(OTCMKTS:XIDEQ) opened its shares at the price of $0.20 for the day. Its closing price was $0.184 after losing -10.24% for the day. The company traded with the total volume of 1.41 million shares, while its average trading volume remained 809,823.00 shares. The beta of XIDEQ stands at 2.54. Exide Technologies manufactures and supplies lead-acid batteries for transportation and industrial applications worldwide.
Has XIDEQ Found The Bottom and Ready To Move Up? Find Out Here
Authentidate Holding Corp.(NASDAQ:ADAT) percentage change surged +18.92% to close at $1.76 with the total traded volume of 1.05 million shares, and average volume of 200,377.00. The 52 week range of the stock remained $0.53 - $1.79, while its day lowest price was $1.43 and it hit its day highest price at $1.79. Authentidate Holding Corp. provides Web-based software applications, and telehealth products and services in the United States.
For How Long ADAT’s Gloss will Attract Investors ? Find out via this report
Orexigen Therapeutics, Inc.(NASDAQ:OREX) started its trading session with the price of $6.02 and closed at $5.68 by scoring -5.18%. OREX’s stocks traded with total volume of 2.90 million shares, while the average trading volume remained 2.33 million shares. The beta of OREX stands at 2.14. Day range of the stock was $5.65 -$6.09. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic, which has completed Phase II clinical trials.
Why Should Investors Buy OREX After the Recent Fall? Just Go Here and Find Out
Newmont Mining Corp(NYSE:NEM) ended its day with the loss of -2.85% and closed at the price of $23.20 after opening at $23.25. Stock traded during its last trading session with the total volume of 11.67 million shares, as compared to its average volume of 9.01 million shares. Newmont Mining Corporation, together with its subsidiaries, engages in the acquisition, exploration, and production of gold and copper properties.
Will NEM Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)